Archives

img-01

Medical device companies blacklisted in China

The State Food and Drug Administration (SFDA) of China has blacklisted 13 companies manufacturing unapproved medical devices. SFDA ran a spot check of 17 provinces, including Beijing, Shanghai, Guangdong, and others. The unapproved medical devices included single-use transfusion machines, metal bone and... Read More

img-01

Asian Harmonization Working Party Updates

The Asian Harmonization Working Party (AHWP) had its last meeting on October 26 and 27 in Chengdu, China, where it discussed schedules and plans for the Common Submission Dossier Template (CSDT), Post-market Alert Systems (PMAS) and other tasks. For CSDT and PMAS,... Read More

img-01

Sourcing Medical Devices in Asia: An Introduction

This report helps medical device manufacturers and distributors better understand how to source from Asia. Topics covered include: how to identify manufacturers, how to perform due diligence, what to look for during factory visits, contract negotiations, regulatory requirements, logistics, quality control, and... Read More

img-01

Six Working Procedures Issued by the SFDA in 2007

In August 2007, China’s State Food and Drug Administration (SFDA) issued six Working Procedures, laying out how it would conduct various procedural requests about medical device product registrations. The most notable of these was a detailed description of how to apply for... Read More

img-01

China Continues to Crack Down on Medical Market

China’s State Food and Drug Administration (SFDA) has recently issued various laws to regulate more stringently quality control in the medical market. The US Department of Health and Human Services (HHS) is also helping China improve its medical market. The HHS and... Read More

img-01

China Continues Plans to Clean up Drug Market

The Chinese State Food and Drug Administration (SFDA) has recently issued a draft regulation “Measures on Managing Registration of Drugs,” which is currently soliciting public opinions on it. These measures outline new guidelines for evaluating drugs before marketing them in China. The... Read More